These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition and Short Chain Fatty Acid Production In Vitro. Perdijk O, van Baarlen P, Fernandez-Gutierrez MM, van den Brink E, Schuren FHJ, Brugman S, Savelkoul HFJ, Kleerebezem M, van Neerven RJJ. Front Immunol; 2019; 10():94. PubMed ID: 30809221 [Abstract] [Full Text] [Related]
4. Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro. Natividad JM, Marsaux B, Rodenas CLG, Rytz A, Vandevijver G, Marzorati M, Van den Abbeele P, Calatayud M, Rochat F. Nutrients; 2022 Jun 19; 14(12):. PubMed ID: 35745275 [Abstract] [Full Text] [Related]
5. Immunomodulation by Human Milk Oligosaccharides: The Potential Role in Prevention of Allergic Diseases. Zuurveld M, van Witzenburg NP, Garssen J, Folkerts G, Stahl B, Van't Land B, Willemsen LEM. Front Immunol; 2020 Jun 19; 11():801. PubMed ID: 32457747 [Abstract] [Full Text] [Related]
6. Utilization of major fucosylated and sialylated human milk oligosaccharides by isolated human gut microbes. Yu ZT, Chen C, Newburg DS. Glycobiology; 2013 Nov 19; 23(11):1281-92. PubMed ID: 24013960 [Abstract] [Full Text] [Related]
11. Varied Pathways of Infant Gut-Associated Bifidobacterium to Assimilate Human Milk Oligosaccharides: Prevalence of the Gene Set and Its Correlation with Bifidobacteria-Rich Microbiota Formation. Sakanaka M, Gotoh A, Yoshida K, Odamaki T, Koguchi H, Xiao JZ, Kitaoka M, Katayama T. Nutrients; 2019 Dec 26; 12(1):. PubMed ID: 31888048 [Abstract] [Full Text] [Related]
12. Infant Microbiota Communities and Human Milk Oligosaccharide Supplementation Independently and Synergistically Shape Metabolite Production and Immune Responses in Healthy Mice. Tripp P, Davis EC, Gurung M, Rosa F, Bode L, Fox R, LeRoith T, Simecka C, Seppo AE, Järvinen KM, Yeruva L. J Nutr; 2024 Sep 26; 154(9):2871-2886. PubMed ID: 39069270 [Abstract] [Full Text] [Related]
15. Utilization Efficiency of Human Milk Oligosaccharides by Human-Associated Akkermansia Is Strain Dependent. Luna E, Parkar SG, Kirmiz N, Hartel S, Hearn E, Hossine M, Kurdian A, Mendoza C, Orr K, Padilla L, Ramirez K, Salcedo P, Serrano E, Choudhury B, Paulchakrabarti M, Parker CT, Huynh S, Cooper K, Flores GE. Appl Environ Microbiol; 2022 Jan 11; 88(1):e0148721. PubMed ID: 34669436 [Abstract] [Full Text] [Related]
16. The human milk oligosaccharides 2'-fucosyllactose and 6'-sialyllactose protect against the development of necrotizing enterocolitis by inhibiting toll-like receptor 4 signaling. Sodhi CP, Wipf P, Yamaguchi Y, Fulton WB, Kovler M, Niño DF, Zhou Q, Banfield E, Werts AD, Ladd MR, Buck RH, Goehring KC, Prindle T, Wang S, Jia H, Lu P, Hackam DJ. Pediatr Res; 2021 Jan 11; 89(1):91-101. PubMed ID: 32221473 [Abstract] [Full Text] [Related]
17. Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model. Castillo-Courtade L, Han S, Lee S, Mian FM, Buck R, Forsythe P. Allergy; 2015 Sep 11; 70(9):1091-102. PubMed ID: 25966668 [Abstract] [Full Text] [Related]
19. 2'-Fucosyllactose (2'-FL) changes infants gut microbiota composition and their metabolism in a host-free human colonic model. Zhang S, Chen L, Hu M, Zhu J. Food Res Int; 2023 Nov 11; 173(Pt 1):113293. PubMed ID: 37803605 [Abstract] [Full Text] [Related]